Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

2015166 citationsJournal Article

Authors

Kathryn C. Fitzgerald · Harvard University

Kassandra L. Munger · Harvard University

Karl Köchert · Bayer (Germany)

Barry G.W. Arnason · University of Chicago

Gıancarlo Comı · San Raffaele University of Rome

Stuart D. Cook · Rutgers, The State University of New Jersey

Douglas S. Goodin

Abstract

Among patients with MS treated with interferon beta-1b, higher 25(OH)D levels were associated with lower rates of MS activity observed on MRI. Results for brain atrophy and clinical progression were more equivocal.

Topics & Keywords

Multiple Sclerosis Research Studies Vitamin D Research Studies Psoriasis: Treatment and Pathogenesis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

Volume 72, Issue 12, pp. 1458-1458

DOI: 10.1001/jamaneurol.2015.2742

Field-Weighted Citation Impact: 11.96